<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphocyte subpopulation composition and spontaneous production of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) by blood cells were studied in 22 and 15 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), respectively, who were under immunosuppressive therapy (IST) </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with hematological response revealed a significantly increased cytotoxic CD8+ lymphocyte concentration and TNF-alpha production </plain></SENT>
<SENT sid="2" pm="."><plain>A direct correlation between TNF-alpha production rate and CD8+ lymphocyte level was established </plain></SENT>
<SENT sid="3" pm="."><plain>Maximum cytokine-producing activity of blood cells was identified in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with enhanced erythroid response </plain></SENT>
<SENT sid="4" pm="."><plain>The study established a great diversity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, its hypoplastic variants and the prognostic value of spontaneous production of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) by blood cells as marker of IST efficacy </plain></SENT>
</text></document>